Delivery Order SPE2DB20D2104-SPE2DB25FMWUQ
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $85,972.33 by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,791.30 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $8,301.00 to AmerisourceBergen Drug Corp on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $6,700.74 to AmerisourceBergen Drug Corp for EBGLYSS 250 MG/2 ML PEN 2ML, a pharmaceutical product for federal medical supply needs. The contract, awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $163,801.69 to AmerisourceBergen Drug Corp on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price, competitively awarded contract (no set-aside) is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled from the...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,639.25 by the Defense Logistics Agency's Medical Supply Chain on July 20, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $41,480.40 to AmerisourceBergen Drug Corp on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside designation...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $19,284.78 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, with an ultimate completion date of July 29, 2025. This is a firm fixed-price, non-set-aside contract with performance to take place in Conshohocken, Pennsylvania. The delivery order represents a child award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $39,192.65 to AmerisourceBergen Drug Corp on July 28, 2025, with a completion date of July 29, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMWUQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,747.38 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ebglyss 250 mg/2 ml pen (2 ml). This firm fixed-price delivery order, with an ultimate completion date of July 30, 2025, represents a competitively awarded, non-set-aside contract with place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child order under a larger contract vehicle, this award demonstrates the company's continued role in fulfilling federal pharmaceutical procurement requirements for military and defense healthcare systems. AmerisourceBergen Drug Corp operates under a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor contract enables the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. The delivery order award reflects the company's established capability and performance as a critical pharmaceutical distributor for federal medical procurement, serving defense health agencies and supporting military personnel and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 7/29/25 |